| Identification | Back Directory | [Name]
Acotiamide hydrochloride trihydrate | [CAS]
773092-05-0 | [Synonyms]
Ym-443
Acotiae
Z-338 HCl
YM-443 HCl
Acotiamide HCl
Unii-nmw7447A9a
Acofide trihydrate
YM-443;ACOTIAMIDE HCL
Acotiamide trihydrate
Acotiamide HCl Hydrate
Acotiamide hydrochlorid
Acorticoid hydrochloride
Acotiamide HCl Trihydrate
Acotiamide hydrochloride hydrate
Acotamine hydrochloride trihydrate
AcotiaMide hydrochloride trihydrate
Acetylformamide hydrochloride trihydrate
Acotiamide hydrochloride trihydrate (YM443
TIANFUCHEM--773092-05-0--Ym-443 factory price
High Quality Acotiamide hydrochloride hydrate
AcotiaMide hydrochloride hydrate CAS 773092-05-0
Bulk AcotiaMide hydrochloride hydrate CAS NO.773092-05-0
Acotiamide hydrochloride hydrate Acotiamide HCl 773092-05-0
Hot sale top quality Acotiamide hydrochloride hydrate with factory price
N-{2-[bis(1-methylethyl)amino]ethyl}-2-[(2-hydroxy-4,5-dimethoxyphenylcarbonyl)amino]
Acofide trihydrate,Acotiamide hydrochloride trihydrate,Acotiamide hydrochloride hydrate
N-(2-(Diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide hydro
N-[2-[DI(PROPAN-2-YL)AMINO]ETHYL]-2-[(2-HYDROXY-4,5-DIMETHOXYBENZOYL)AMINO]-1,3-THIAZOLE-4-CARBOXAMIDE
N-{2-[bis(1-methylethyl)amino]ethyl}-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-,hydrochloride,hydrate (1:1:3)
N-[2-(Diisopropylamino)ethyl]-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide Hydrochloride Trihydrate
N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide,trihydrate,hydrochloride
N-(2-(Diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-1,3-thiazole-4-carboxyamide monohydrochloride trihydrate
N-[2-[Bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide monohydrochloride trihydrate
4-Thiazolecarboxamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-,hydrochloride,hydrate(1:1:3)
4-((4-((2-(diisopropylamino)ethyl)carbamoyl)thiazol-2-yl)carbamoyl)-5-hydroxyphthalic acid hydrochloride trihydrate (Acotiamide HCl Trihydrate) | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C21H31ClN4O5S | [MDL Number]
MFCD28101055 | [MOL File]
773092-05-0.mol | [Molecular Weight]
487.013 |
| Chemical Properties | Back Directory | [Melting point ]
193-195o C | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Chloroform (Slightly, Heated, Sonicated), DMSO (Slightly) Methanol (Slightly) | [form ]
Solid | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Description]
In June 2013, the Ministry of Health, Labor and Welfare in Japan approved acotiamide (also referred to as Z-338 and YM443), for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia (FD). Acotiamide enhances acetylcholine release from enteric neurons through selective muscarinic acetylcholine receptor M1, M2 antagonism, and inhibition of AChE, thereby enhancing gastric emptying and gastric accommodation. Acotiamide inhibits the acetylcholine-induced Ca2+-activated Cl-current with an IC50 of 1.8 μM in oocytes expressing muscarinic M1 receptors and in oocytes expressing muscarinic M2 receptors, acotiamide inhibited the acetylcholine-induced K+ currents with an IC50 of 10.1 μM. However, studies in conscious dogs, guinea-pig gastric muscle strips and assays with human cholinesterase indicate that acotiamide inhibits AChE with a Ki of 610 nM suggesting that acotiamide stimulates gastric motility mainly by inhibiting AChE activation. In a restraint stress-induced rat model, acotiamide significantly improved delayed gastric emptying and feeding inhibition but did not affect normal gastric emptying or feeding in intact rats. A synthetic route to acotiamide that employs pyridine hydrochloride to selectively cleave a 2-substituted methyl ether from a 2,4,5-trimethoxy benzamide intermediate, as a key step, has been reported. | [Originator]
Zeria Pharmaceutical (Japan) | [Uses]
Acofide Trihydrate is a gastrointestinal prokinectic agent used in the treatment of functional malnutrition. A tablet for the treatment of functional dyspepsia. | [Brand name]
Acofide | [Synthesis]
Commercial 3,4,5-trimethoxybenzoic acid was first converted
to the corresponding acid chloride, which was isolated
by co-distillation with hexane. In refluxing dichloroethane (DCE),
the acid chloride was coupled with the commercially available
thiazole amine to give the desired amidothiazole in 89% yield.
From this intermediate, amide linkage, selective demethylation of
the 2-methoxy group, salt formation, and recrystallization were
accomplished in the following sequence: the thiazole ester was
reacted with N,N-diisopropyl ethylenediamine in DMA at elevated
temperatures. Upon cooling, the mixture was dissolved in
n-butanol and washed with aqueous sodium hydroxide.
Subsequent treatment with HCl gas in isopropanol gave the
corresponding HCl salt as crystals that could be collected by filtration.
The product obtained was further crystallized from 4:1 isopropanol
and water to give the desired product acotimide (I) as
the hydrochloride trihydrate in 71% yield.
|
|
|